Why the study?
Is ApoB an effective marker for identifying familial hyperlipoproteinemia in children?
Is ApoB an effective marker for identifying familial hyperlipoproteinemia in children?
ApoB is an important marker of familial hyperlipoproteinemia that can identify families needing primary CHD prevention.
Answers are grounded in this paper and cite their sources.
May support ApoB screening in children for familial hyperlipoproteinemia; hypothesis-generating, prospective studies needed before practice change.
Of the 109 children examined due to the child's increased apoB concentration, about 20% were obese and 75% had an increased LDLC concentration. A familial occurrence of hyperlipoproteinemia was evident in about 50% of the families with an hyperapoB child. Six families probably suffer from familial hypercholesterolemia. The definite number of FCHL families could not be defined since extended pedigrees were not available. A high suspicion of FCHL was evident in 20 families. ApoB is an important marker of hyperlipoproteinemia of familial occurrence identifying families in need of primary CHD prevention.
No takes yet. Share an insight, caveat, or question.
Sveger et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: